Instuitional Investor - Aisling Capital Management Lp

13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Bridgebio Pharma Inc.	BBIO	6,089,611	$316,294,395	69.29%
2.	Verona Pharma Plc	VRNA	615,352	$65,664,212	14.39%
3.	Syndax Pharmaceuticals Inc	SNDX	1,316,806	$20,265,644	4.44%
4.	Nuvation Bio Inc.	NUVB	2,960,659	$10,954,438	2.4%
5.	Monte Rosa Therapeutics Inc.	GLUE	1,472,331	$10,909,973	2.39%